Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.

Should anticoagulation be resumed after intracerebral hemorrhage? Cleve Clin J Med (2010) 1.53

Experimental model of warfarin-associated intracerebral hemorrhage. Stroke (2008) 1.48

Emergency neurological care of strokes and bleeds. J Emerg Trauma Shock (2010) 1.39

Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage. Blood Transfus (2011) 1.14

Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage. Circulation (2011) 1.10

Experimental intracerebral hemorrhage: avoiding pitfalls in translational research. J Cereb Blood Flow Metab (2011) 1.02

Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: a structured literature review. Int J Emerg Med (2011) 1.01

Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage. J Cereb Blood Flow Metab (2009) 1.00

Dengue hemorrhagic fever and severe thrombocytopenia in a patient on mandatory anticoagulation: balancing two life threatening conditions: a case report. BMC Infect Dis (2012) 0.95

Management of acute stroke in patients taking novel oral anticoagulants. Int J Stroke (2014) 0.89

Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy. World J Cardiol (2011) 0.85

Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy. Int J Emerg Med (2009) 0.84

Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies. Lancet Neurol (2013) 0.83

Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage. Stroke (2011) 0.83

Reversal of oral anticoagulation. Pharmacotherapy (2013) 0.82

Reversal of warfarin-induced hemorrhage in the emergency department. West J Emerg Med (2011) 0.82

A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal. Crit Care (2013) 0.81

Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography. Stroke (2013) 0.81

Progressing haemorrhagic stroke: categories, causes, mechanisms and managements. J Neurol (2014) 0.78

Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case-control study. BMC Neurol (2012) 0.78

Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice. Crit Care (2012) 0.78

Warfarin-associated intracerebral hemorrhage. Neurol Sci (2008) 0.78

Oral anticoagulant-associated intracerebral hemorrhage. J Neurol (2011) 0.77

The persisting burden of intracerebral haemorrhage: can effective treatments be found? PLoS Med (2010) 0.75

Management dilemmas in patients with mechanical heart valves and warfarin-induced major bleeding. World J Cardiol (2012) 0.75

Prophylactic Fresh Frozen Plasma Infusion is Ineffective in Reversing Warfarin Anticoagulation and Preventing Delayed Intracranial Hemorrhage After Falls. Neurohospitalist (2015) 0.75

Intracranial hemorrhage. Emerg Med Clin North Am (2012) 0.75

Brain hemorrhage: restarting anticoagulation after intracranial hemorrhage. Nat Rev Neurol (2011) 0.75

Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays. BMC Health Serv Res (2015) 0.75

Antithrombotic medicines following intracerebral haemorrhage: where's the evidence? Ther Adv Drug Saf (2011) 0.75

Fluid levels in the bleeding brain: a marker for coagulopathy and hematoma expansion. Intern Emerg Med (2017) 0.75

Resumption of Anticoagulation After Intracranial Hemorrhage. Curr Treat Options Neurol (2017) 0.75

Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18

Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke (2007) 12.77

Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med (2009) 11.49

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 11.00

Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2005) 9.58

Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol (2008) 7.50

Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93

Community-acquired bacterial meningitis in adults. N Engl J Med (2006) 6.65

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol (2013) 6.18

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Idarucizumab for Dabigatran Reversal. N Engl J Med (2015) 5.91

Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2008) 5.77

Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med (2012) 5.69

Genomewide association studies of stroke. N Engl J Med (2009) 5.29

Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation (2007) 5.28

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke (2006) 5.04

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Lancet (2007) 4.99

The lifetime risk of stroke: estimates from the Framingham Study. Stroke (2006) 4.68

Variability of brain death determination guidelines in leading US neurologic institutions. Neurology (2007) 4.50

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation (2004) 4.45

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11

Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke (2009) 3.89

Depressive symptoms and risk of stroke: the Framingham Study. Stroke (2006) 3.80

Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke (2010) 3.75

Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60

Dementia after stroke: the Framingham Study. Stroke (2004) 3.53

Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA (2006) 3.50

Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2011) 3.48

Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation. Ann Intern Med (2009) 3.44

Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40

Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke (2002) 3.36

Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2014) 3.36

Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke (2009) 3.23

The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovasc Dis (2007) 3.22

Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke (2003) 3.12

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol (2011) 3.08

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med (2004) 3.06

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol (2010) 2.99

Prediction of potential for organ donation after cardiac death in patients in neurocritical state: a prospective observational study. Lancet Neurol (2012) 2.95

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA (2002) 2.94

Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol (2012) 2.94

Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke (2004) 2.92

Renal failure and posterior reversible encephalopathy syndrome in patients with thrombotic thrombocytopenic purpura. Arch Neurol (2010) 2.91

Body mass index and the risk of stroke in men. Arch Intern Med (2002) 2.90

Continuous electroencephalography in the medical intensive care unit. Crit Care Med (2009) 2.86

Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke (2008) 2.84

National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82

Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke (2011) 2.81

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77

Genetic variation and neuroimaging measures in Alzheimer disease. Arch Neurol (2010) 2.76

Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation (2005) 2.73

Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke (2008) 2.72

Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ (2010) 2.63

Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med (2006) 2.58

Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery (2009) 2.58

Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med (2008) 2.57

Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial. Stroke (2005) 2.56

Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis. Arch Neurol (2009) 2.55

Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol (2009) 2.55

Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study. BMC Med Genet (2007) 2.51

Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke (2005) 2.49

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2006) 2.42

Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke (2005) 2.36

Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36

The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35

Severity of leukoaraiosis and susceptibility to infarct growth in acute stroke. Stroke (2008) 2.34

Predictors of neurologic outcome in hypothermia after cardiac arrest. Ann Neurol (2010) 2.33

Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol (2010) 2.31

Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke (2009) 2.28

Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality. Neurocrit Care (2012) 2.25

Amyloid angiopathy-related vascular cognitive impairment. Stroke (2004) 2.21

Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score. Stroke (2009) 2.20

The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor. Int J Stroke (2014) 2.18

Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation (2011) 2.17

Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 2.17

Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia (2002) 2.14

Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke (2002) 2.13

ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection? Neurology (2014) 2.08

Parental occurrence of stroke and risk of stroke in their children: the Framingham study. Circulation (2010) 2.07

"Computed tomography-negative" intracerebral hemorrhage: case report and implications for management. Arch Neurol (2003) 2.06

Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). Stroke (2008) 2.06

A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med (2003) 2.04

Healthy lifestyle and the risk of stroke in women. Arch Intern Med (2006) 2.02

Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med (2007) 1.97

Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke (2004) 1.96

World Stroke Organization global stroke services guidelines and action plan. Int J Stroke (2014) 1.94

Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis (2006) 1.91

Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation (2010) 1.90

Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90

Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage. Stroke (2012) 1.89

Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care (2006) 1.89

The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors. Stroke (2009) 1.89

Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke (2004) 1.88